UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

PloS one, 2022-10, Vol.17 (10), p.e0275901-e0275901

2022

Volltextzugriff (PDF)

Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass

Obesity surgery, 2020-03, Vol.30 (3), p.1038-1045

2020

Volltextzugriff (PDF)

Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

Diabetes care, 2022-06, Vol.45 (6), p.1476-1481

2022

Volltextzugriff (PDF)

A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals

Obesity surgery, 2020-04, Vol.30 (4), p.1605-1610

2020

Volltextzugriff (PDF)

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

PloS one, 2022-10, Vol.17 (10)

2022

Volltextzugriff (PDF)

Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists

Current diabetes reviews, 2009-11, Vol.5 (4), p.266-275

2009

Volltextzugriff (PDF)

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Diabetes care, 2011-07, Vol.34 (7), p.1463-1468

2011

Volltextzugriff (PDF)

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Diabetes (New York, N.Y.), 2011-05, Vol.60 (5), p.1599-1607

2011

Volltextzugriff (PDF)

Quality of Life is Markedly Impaired by Rheumatological and Skin Manifestations in Patients with Type 1 Diabetes: A Questionnaire Survey

Diabetes therapy, 2019-04, Vol.10 (2), p.635-647

2019

Volltextzugriff (PDF)

Postprandial hypoglycaemia after Roux‐en‐Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide

Diabetes, obesity & metabolism, 2019-09, Vol.21 (9), p.2142-2151

2019

Volltextzugriff (PDF)

Kinetics of insulin and C-peptide and estimation of prehepatic insulin secretion rates after intravenous glucose stimulation using arterial versus venous blood sampling in healthy males

Scandinavian journal of clinical and laboratory investigation, 2024-02, Vol.84 (1), p.16-23

2024

Volltextzugriff (PDF)

Influence of Sex and Other Risk Factors, Including Kidney Function, on Myocardial Microvascular Function in Individuals with Type 2 Diabetes Free of Overt Cardiovascular Disease: The DiaHeart Study: FR-PO335

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

A Response to “The Relationship Between Sleep and Quality of Life in Type 1 Diabetes Patients”

Diabetes therapy, 2019-06, Vol.10 (3), p.1173-1174

2019

Volltextzugriff (PDF)

Acarbose and Pasireotide Reduce Hypoglycemia in Roux-en-Y Gastric Bypass Operated Subjects

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

2073-P: Are Early Dumping and Postprandial Hypoglycemia after Roux-en-Y Gastric Bypass Related Events?

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial

Diabetes, obesity & metabolism, 2024-11, Vol.26 (11), p.4905-4915

2024

Volltextzugriff (PDF)

10-LB: Dasiglucagon Ameliorates Postprandial Hypoglycemia after Roux-en-y Gastric Bypass

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients

The journal of clinical endocrinology and metabolism, 2010-05, Vol.95 (5), p.2492-2496

2010

Volltextzugriff (PDF)

Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass

Surgery for obesity and related diseases, 2021-01, Vol.17 (1), p.55-63

2021

Volltextzugriff (PDF)

59-OR: Liraglutide Preserved Insulin Secretion in Adults with Newly Diagnosed Type 1 Diabetes: The NewLira Trial

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual [beta]-cell function

Diabetes (New York, N.Y.), 2011-05, Vol.60 (5), p.1599

2011

Volltextzugriff (PDF)

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

Diabetes & vascular disease research, 2022-09, Vol.19 (5), p.147916412211300-14791641221130043

2022

Volltextzugriff (PDF)

Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual β-cell function

Diabetes care, 2011-07, Vol.34 (7), p.1463

2011

Volltextzugriff (PDF)

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual [Beta]-Cell Function

Diabetes care, 2011-07, Vol.34 (7), p.1463

2011

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass

Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Quality of Life is Markedly Impaired by Rheumatological and Skin Manifestations in Patients with Type 1 Diabetes: A Questionnaire Survey

Postprandial hypoglycaemia after Roux‐en‐Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide

Kinetics of insulin and C-peptide and estimation of prehepatic insulin secretion rates after intravenous glucose stimulation using arterial versus venous blood sampling in healthy males

Influence of Sex and Other Risk Factors, Including Kidney Function, on Myocardial Microvascular Function in Individuals with Type 2 Diabetes Free of Overt Cardiovascular Disease: The DiaHeart Study: FR-PO335

A Response to “The Relationship Between Sleep and Quality of Life in Type 1 Diabetes Patients”

Acarbose and Pasireotide Reduce Hypoglycemia in Roux-en-Y Gastric Bypass Operated Subjects

2073-P: Are Early Dumping and Postprandial Hypoglycemia after Roux-en-Y Gastric Bypass Related Events?

Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial

10-LB: Dasiglucagon Ameliorates Postprandial Hypoglycemia after Roux-en-y Gastric Bypass

396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes

Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients

Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass

59-OR: Liraglutide Preserved Insulin Secretion in Adults with Newly Diagnosed Type 1 Diabetes: The NewLira Trial

Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual [beta]-cell function

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual β-cell function

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual [Beta]-Cell Function

Suchergebnisse filtern